We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Nuformix PLC 19 March 2024 Nuformix plc ("Nuformix" or the "Company") Result of Annual General Meeting Nuformix plc (LSE: NFX), a pharmaceutical development company targeting unmet medical...
ndon-based developer of treatments for fibrosis and oncology via drug repurposing - Announce intention to raise gross ...
Nuformix PLC 01 March 2024 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATIONS (EU) NO. 596/2014 WHICH FORMS PART OF DOMESTIC UK LAW...
Nuformix PLC 15 January 2024 15 January 2024 Nuformix plc ("Nuformix", the "Company" or the "Group") Posting of Annual Report and Notice of Annual General Meeting...
ndon-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 ...
Nuformix PLC 03 January 2024 3 January 2024 Nuformix plc ("Nuformix", the "Company" or the "Group") Annual Results for the period ended 30 September 2023 Nuformix...
Nuformix PLC 18 December 2023 18 December 2023 Nuformix plc ("Nuformix" or the "Company") NXP001 Update Nuformix receives second NXP001 milestone payment from Oxilio Nuformix...
Nuformix PLC on Monday said it has been issued with a patent in Japan for NXP002, its potential novel inhaled treatme ...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.005 | -2.43902439024 | 0.205 | 0.2075 | 0.18 | 1650926 | 0.19995354 | DE |
4 | 0.01 | 5.26315789474 | 0.19 | 0.23 | 0.18 | 1754689 | 0.19785061 | DE |
12 | -0.11 | -35.4838709677 | 0.31 | 0.31 | 0.18 | 2221601 | 0.21005057 | DE |
26 | -0.07 | -25.9259259259 | 0.27 | 0.44 | 0.18 | 2456158 | 0.26910833 | DE |
52 | -0.02 | -9.09090909091 | 0.22 | 0.44 | 0.18 | 3102533 | 0.26578234 | DE |
156 | -2.15 | -91.4893617021 | 2.35 | 2.6 | 0.18 | 4211244 | 0.79315687 | DE |
260 | -2.8 | -93.3333333333 | 3 | 14.75 | 0.18 | 4391996 | 2.88791605 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions